Meditoxin 200 – High-Dose Botulinum Toxin Type A for Broad Aesthetic and Therapeutic Use
1. Product Overview & Manufacturer
Meditoxin 200 is a botulinum toxin type A developed by Medytox Inc., a globally recognized South Korean biopharmaceutical company specializing in advanced botulinum technologies. As the 200-unit version of the Meditoxin product line, this formulation is specifically designed for practitioners who require larger doses for full-face cosmetic procedures or therapeutic indications.
2. Composition & Packaging
- 
Each vial contains 200 units of highly purified Clostridium botulinum toxin type A in a lyophilized (freeze-dried) powder form.
 - 
Must be reconstituted with sterile 0.9% saline (NaCl) before injection.
 
3. Mechanism of Action
Meditoxin 200 works by blocking the release of acetylcholine at neuromuscular junctions. This causes temporary inhibition of muscle contractions, resulting in:
- 
Relaxation of facial or body muscles
 - 
Reduction of expression lines and dynamic wrinkles
 - 
Control of excessive sweating (hyperhidrosis)
 - 
Relief of medical conditions involving muscular tension or spasticity
 
4. Clinical Advantages
- 
High-dose efficiency: Ideal for multi-zone aesthetic treatments, masseter reduction, or therapeutic interventions.
 - 
Fast-acting: Results typically begin to appear within 3 to 5 days.
 - 
Long-lasting effects: Results can last 3 to 6 months, depending on treatment area and individual metabolism.
 - 
High purity and low protein content, reducing the likelihood of immune resistance.
 - 
Smooth and predictable diffusion, ensuring precise, natural-looking outcomes.
 
5. Aesthetic & Therapeutic Applications
- 
Aesthetic Uses:
- 
Full-face wrinkle treatment (forehead, frown lines, crow’s feet)
 - 
Masseter hypertrophy (jaw slimming)
 - 
Chin dimpling, bunny lines, neck bands
 - 
Trapezius or calf muscle slimming
 
 - 
 - 
Medical Uses:
- 
Hyperhidrosis (palms, soles, underarms)
 - 
Blepharospasm, cervical dystonia
 - 
Post-stroke spasticity (off-label)
 - 
Migraine relief (off-label)
 - 
Bruxism, TMJ disorders (off-label)
 
 - 
 
6. Certification & Global Recognition
- 
Approved by the Korean MFDS (Ministry of Food and Drug Safety)
 - 
Manufactured under strict GMP (Good Manufacturing Practice) compliance
 - 
Exported to over 60 countries, with growing clinical trust worldwide
 - 
Extensively clinically tested for safety and efficacy
 
7. Storage & Handling
- 
Store between 2–8°C, away from direct light
 - 
Do not freeze
 - 
Reconstituted solution should be used within the manufacturer’s recommended timeframe
 - 
Administered exclusively by trained, licensed medical professionals
 

ToxTa 100						



				





				
				
				
				
				
				
				
				
Reviews
There are no reviews yet.